GRACELL BIOTECHNOLOGIES-ADR (GRCL) Stock Analyst Earnings Estimates
NASDAQ:GRCL - Nasdaq - US38406L1035 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 370K | -100.00% | 149.52M | 661.89M 342.68% | 1.629B 146.11% | 2.883B 76.98% | 4.285B 48.63% | ||||||
| EBITDA YoY % growth | -141.46M -137.71% | -192.81M -36.30% | -418.7M -117.16% | -88.626M -35.15% | -95.473M 83.13% | -114.057M -19.47% | -124.135M -8.84% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -146.58M -134.53% | -214.4M -46.27% | -463.57M -116.22% | -100.732M -34.75% | -80.929M 87.04% | -94.784M -17.12% | -110.106M -16.17% | -848.906M -670.99% | -678.31M 20.10% | -327.978M 51.65% | 435.36M 232.74% | 1.322B 203.66% | |
| Operating Margin | N/A | N/A | -125,289.19% | N/A | N/A | N/A | N/A | -567.75% | -102.48% | -20.13% | 15.10% | 30.85% | |
| EPS YoY % growth | N/A | N/A | -1.05 -2.28% | -0.69 -23.81% | -0.91 29.78% | -0.55 39.39% | -1.14 -106.45% | -4.02 -251.68% | -3.09 23.18% | -2.43 21.11% | 0.63 126.00% | 4.33 584.57% |
All data in CNY
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 52.40% | -0.21 38.80% | -0.21 28.60% | -0.22 -124.40% | -0.22 -57.14% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -19.207M 78.78% | -21.357M | -23.721M 79.47% | -26.323M | N/A |
| EBIT Q2Q % growth | -19.236M 87.12% | -22.508M 86.49% | -22.95M 83.74% | -23.46M -5.50% | -23.984M -24.68% |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.10 71.43% | -0.20 | 0.10 | 50.15% |
| Q2 2023 Q2Q % growth | -0.30 | -0.41 | 0.11 | 26.47% |
| Q1 2023 Q2Q % growth | -0.35 | -0.40 | 0.05 | 13.13% |
| Q4 2022 Q2Q % growth | -0.30 | -0.21 | -0.09 | -42.78% |
| Q3 2022 Q2Q % growth | -0.35 -16.67% | -0.15 | -0.20 | -136.32% |
| Q2 2022 Q2Q % growth | -0.30 -50.00% | -0.08 | -0.22 | -283.62% |
| Q1 2022 Q2Q % growth | -0.35 -40.00% | -0.21 | -0.14 | -63.40% |
| Q4 2021 Q2Q % growth | -0.30 -87.50% | -0.34 | 0.04 | 10.87% |
| Q3 2021 Q2Q % growth | -0.30 | -0.12 | -0.18 | -145.10% |
| Q2 2021 Q2Q % growth | -0.20 | -0.12 | -0.08 | -68.06% |
| Q1 2021 Q2Q % growth | -0.25 | -0.22 | -0.03 | -14.89% |
| Q4 2020 Q2Q % growth | -0.16 | -0.26 | 0.10 | 38.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -100.00% | 25.5K | -25.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 22.51% |
| Revenue | N/A | N/A | N/A | N/A |